We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“It is really important to make room in the guideline process for considering sex-specific data. We recognize that the level of evidence may not be of the highest class and there may be limitations to the data available. Still, whether it's coronary artery disease or heart failure, there should at least be some consideration by the committee whether the level of evidence proposed should be modified depending on patient sex.”
No takes yet. Share an insight, caveat, or question.
DeFilippis et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: